Abstract:Objective:To explore the of traditional Chinese medicine on liver lipid per-oxidation and pathology in nonalcoholic fatty liver disease(NAFLD)rats.Methods:Fetched 72 wistar rats' level of SPF,females and males were half and half,were divided into 9 groups at random:normal group,model group,comparison medicine treatment group,medicine A treatment group,medicine B treatment group,first Medicine A then medicine B treatment group,first medicine B then medicine A treatment group,first blank then medicine A treatment group,first blank then,medicine B treatment group.Except the normal group was fed ordinary diet,the other eight groups were fed by high fat and high cholesterol diet.After 4 weeks later,model group rats were given hpysiological saline by intragastric administration.Comparison medicine treatment group rats were given comparision medicine by intragastric administration.Medicine A treatment group rats were given medicine A by intragastric administration.Medicine B treatment group rats were given medicine B by intragastric administration.First medicine A then medicine B treatment group rats were given medicine A from 4 weeks to 8 weeks and medicine B from 8 weeks to 12 weeks by intragastric administration.First medicine B then medicine A treatment group rats were given medicine B from 4 weeks to 8 weeks and medicine A from 8 weeks to 12 weeks by intragastric administration.First blank then medicine A treatment group rats were given nothing from 4 weeks to 8 weeks and medicine A from 8 weeks to 12 weeks by intragastric administration.First blank then medicine B treatment group rats were given nothing from 4 weeks to 8 weeks and medicine B from 8 weeks to 12 weeks by intragastric administration.At the end of the 12 weeks,we determined the content of SOD,MDA and GSH-ST and evaluated the degree of fat denatured and the activity of pathology inflammation in rat liver organization.Results:At the end of the 12 weeks,first medicine A then medicine B treatment group had better curative effect than other treatment groups at raising the content of SOD and GSH-ST(P0.01),and reducing the peroxide content of MDA(P0.01 or P0.05)in rat liver organization;ln pathology influence aspect,first medicine A then medicine B treatment group had better curative effect than other treatment groups at relieving the degree of fat denatured and the activity of pathology inflammation in later stage of NAFLD rats(P0.01 or P0.05).Conclusion:In NAFLD entire course of disease,treatment plan of applying therapy of dispersing the depressed liver-energy to invigorate the spleen,activating blood circulation to dissipate blood stasis and dissipating phlegm to decrease wet in early stage,using therapy of dissipating phlegm to dissipate blood stasis,clearing away heat evil to decrease wet and benefiting hepatorenal function in later stage,which had better curative effect than other remedial measures at elevating fatty liver cell oxidation resistance ability,reducing the lipid peroxidation product,the degree of fat denatured and the activity of pathology inflammation in NAFLD rats.

Therapeutic Effect and the Influence of the ERS Regulated Factors Research of Qiwei Tiexie Capsule on Non-Alcoholic Fatty Liver Rats

Effect of Pu-erh Tea on Long Chain Fatty Acid Metabolism and Expression of Tight Junction Proteins in the Rat Model of Non-alcoholic Fatty Liver Disease

Lactobacillus Casei YRL577 Combined with Plant Extracts Reduce Markers of Non-Alcoholic Fatty Liver Disease in Mice

Experimental Study of Amydae Carapax Decoction on Prevention & Treatment of Liver Fibrosis in Rats Induced by Two Different Causes

Effect of Xuezhikang Capsule (血脂康胶囊) on serum tumor necrosis factor-α and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Experimental Study of Amydae Carapax on Prevention & Treatment of Liver Fibrosis

The role of dietetic treatment in non-alcoholic fatty liver disease of rats

Study on clinical effect of Yiqi Yangyin and Huoxue Prescription imposed on fatty liver in type 2 diabetes mellitus

Therapeutic Effect of Puerarin on Non-Alcoholic Rat Fatty Liver by Improving Leptin Signal Transduction Through JAK2/STAT3 Pathways

[Effect of Soothing Liver and Invigorating Spleen Recipes on SREBP-1c Mrna and Protein Expression in Hepatic Tissues of Rats with Non-Alcoholic Fatty Liver Disease].

Effect of Modified Xiaoxianxiong Tang(小陷胸汤)on Liver Caspase-12 Expression in Rats with Nonalcoholic Fatty Liver Disease

Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease

Influence of traditional Chinese medicine on liver lipid per-oxidation and pathology in NAFLD rats

Influence of Soothing Liver and Invigorating Spleen Recipes on LXR Alpha mRNA of Liver Tissue and Protein Expression of NAFLD Rats

Effect of Yuqin Capsule on Cytokins in Treating Non-Alcoholic Fatty Liver Disease Patients

Therapeutic effect of Dahuang Zhechong Pills on chronic fatty liver in rats

Epigallocatechin gallate alleviates Non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4

Experimental Study on Effect of Traditional Chinese Medicine Dialectical Treating Blood-fat Index on NAFLD Rats

Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease

Effects of Soothing Liver and Invigorating Spleen Recipes of TCM on Hepatic Inflammatory Cytokines of Rats with Nonalcoholic Steatosishepatitis